Research Article
Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port
Table 1
Clinical data on 31 consecutive patients given chemotherapy through a permanent intraperitoneal port placed prior to the closure of the abdomen.
| Gender | | Male | 16 | Female | 15 | Age | | Median | 49 | Range | 32–74 | Diagnosis | | Peritoneal mesothelioma | 19 | Appendiceal adenocarcinoma | 5 | Papillary serous cancer | 3 | Pancreas cancer | 3 | Rectal cancer | 1 | Cytoreduction | | Complete or near complete (CC-0/CC-1) | 23 | Incomplete cytoreduction | 8 | % of patients completing 5 or more cycles of with adverse events requiring removal of intraperitoneal port | | Complete or near complete cytoreduction | 9% (2/23) | Incomplete cytoreduction | 75% (6/8) |
|
|